00731nas a2200205   4500000000100000008004100001260005500042653001200097653000900109653001100118653001800129653001400147100001400161700001500175245016600190856012100356300001600477490000700493022002500500       2026                            d  c06/2026bOvid Technologies (Wolters Kluwer Health)10aDapsone10aacne10aSafety10aEffectiveness10aTreatment1 aMukhida S1 aAthavale P00aUse of dapsone nonjudicially in acne: Can this lead to resistance in leprosy? Comments on safety and effectiveness of topical dapsone in acne treatment: A review  uhttps://www.ovid.com/jnls/jfmpc/pdf/10.4103/jfmpc.jfmpc_505_26~use-of-dapsone-nonjudicially-in-acne-can-this-lead-to  a2355 - 23560 v15  a2249-4863, 2278-7135